Due to their significant impact on human life since their domestication, dogs are viewed as the most appropriate companion animal in humans. They promote an active lifestyle, provide emotional companionship, and have superior detection capabilities for several purposes. Pets help bring social, emotional, and cognitive development in children, in addition to helping adults in relieving stress and anxiety. Research studies have shown that dog owners are at a 36% lower risk of dying from cardiovascular disease and an 11% lower risk of a heart attack. According to the Animal Wellbeing (PAW) Report 2019 by the People's Dispensary for Sick Animals (PDSA), ~50% of the UK population owns a pet. 26% of adults own a dog, with an estimated population of 9.9 million pet dogs. Thus, the surging preference for dogs as a companion is fueling the therapeutic dog food market growth.
As a result of COVID-19 pandemic, the demand for pets, especially kittens and puppies, increased significantly in Asia Pacific. According to several industry press reports, many pet shops revealed that they were unable to maintain pets in inventory on display due to record sales between May and July 2020. Usually, summer represents a low sales season with a greater number of kittens available on discount, but this past year the price for pets did not decrease. The distribution of GOJ’s special fixed-amount benefit of 100,000 yen (about US$ 920) per person seems to have spurred an increase in pet purchases. Experts in the industry see this as a temporary phenomenon but anticipate additional increases in the sales of pet-related products, such as therapeutic dog food, in Asia Pacific. This change has already been confirmed across varieties of pet foods used for weight management, digestive care, and allergy and immune system health, with increased sales of higher-priced wet and semi-moist types. In addition, a few industry press reports showed a 10 to 15% increase in the sales of pet foods as several pet owners stockpiled pet foods together with their groceries.
With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific therapeutic dog food market. The therapeutic dog food market is improving with initiatives led by animal welfare associations, dog food manufacturers, and governments. Governments are raising awareness concerning health conditions and animal diseases, and also facilitating the privatization of animal healthcare services. For instance, the Japanese Government implemented the law for pet food manufacturers, importers, and wholesalers to ensure the safety of these products for protecting pets and regulating manufacturing process. The PetFAST Reporting System tracks any suspected pet illness associated with pet food sold in the country. Such systems urge the manufacturers to maintain optimum product quality and hence assist in augmenting the brand identity of the products and thus facilitate the market growth. A surge in pet ownership and growing consumer awareness has spurred demand for pet products, and companies are launching various campaigns to increase consumer awareness. For instance, in June 2021, MARS Petcare introduced a new advertising campaign promoting Pedigree’s Small Dog pet food range in India. The new advertising campaign promotes the concept of feeding the right food to small dogs.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,189.74 Million |
| Market Size by 2028 | US$ 1,800.41 Million |
| CAGR (2021 - 2028) | 6.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Therapeutic Dog Food Market is valued at US$ 1,189.74 Million in 2021, it is projected to reach US$ 1,800.41 Million by 2028.
As per our report Asia Pacific Therapeutic Dog Food Market, the market size is valued at US$ 1,189.74 Million in 2021, projecting it to reach US$ 1,800.41 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The Asia Pacific Therapeutic Dog Food Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Therapeutic Dog Food Market report:
The Asia Pacific Therapeutic Dog Food Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Therapeutic Dog Food Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Therapeutic Dog Food Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Therapeutic Dog Food Market
